Lithuania Suspends AstraZeneca Vaccinations

  Lithuania on Tuesday followed more than a dozen other countries in suspending AstraZeneca vaccinations pending checks by the European Medicines Agency (EMA). Advertisement Health … Continue reading Lithuania Suspends AstraZeneca Vaccinations


In this file photo an illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes with the logo of British pharmaceutical company AstraZeneca on November 17, 2020. A scientific committee advising the Canadian government on Covid-19 vaccines on March 16, 2021 broadened its recommendation for the use of AstraZeneca jabs to include people aged 65 and over. The National Advisory Committee on Immunization said there was now “real-world evidence” of the vaccine’s effectiveness in seniors, reversing its earlier position that not enough people in this age group had been included in clinical trials to make a determination.
FILES) In this file photo an illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes with the logo of British pharmaceutical company AstraZeneca on November 17, 2020. 

 

Lithuania on Tuesday followed more than a dozen other countries in suspending AstraZeneca vaccinations pending checks by the European Medicines Agency (EMA).

Health Minister Arunas Dulkys said the vaccine will not be used as a precaution “until the European Medicines Agency provides its final conclusions over its safety”.

Dulkys said that, while he “personally trusted” the vaccine and was ready to take the AstraZeneca shot, the temporary halt was the “safest solution” to minimise risks.

Lithuania’s medicines control agency said three people have developed blood clots in the Baltic state of 2.8 million people after taking the vaccine, but said it has no indications that the vaccine has caused them.

The EU’s medicines regulator has said it is looking at any serious side effects of all coronavirus vaccines and is expected to publish its conclusions on Thursday.

But the EMA said on Tuesday it was “firmly convinced” the benefits of AstraZeneca’s jab outweigh potential risks, insisting there was no evidence linking it to blood clots.

More than a dozen countries, including the EU’s biggest members France, Germany, and Italy, have suspended the jabs.

-AFP